Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.
Movsas B, Teruya-Feldstein J, Smith J, Glatstein E, Epstein AH
Primary cardiac sarcoma - A novel treatment approach
Chest (1998) 114:648-652.
Primary cardiac sarcomas carry a dismal prognosis with no known curative therapy using standard treatment approaches. By its very location, the possibility of a radical complete resection- the underlying principle in the management of any soft-tissue sarcoma-is precluded. While literally in a continuous "blood bath," cardiac sarcomas are associated with a very high rate of hematogenous metastases. This report describes the management of a case in a 51-year-old white man with a high-grade unresectable cardiac sarcoma who was treated with hyperfractionated (twice daily) radiotherapy to a total dose of 7,050 eGy along with a radiosensitizer, (5'-iodode-oxyuridipne. The patient currently is disease-free and functioning well more than 5 years following this novel treatment approach.
Publication Date: 1998-08-01.
Last updated on Wednesday, July 08, 2020